Introduction: The brain demonstrates spontaneous low-frequency (< 0.1 Hz) CBF fluctuations, measurable by resting-state functional MRI (RS-fMRI). Ultra small superparamagnetic iron oxide (USPIO) particles have been shown to enhance task-based fMRI signals (CBV-fMRI), compared to the BOLD effect, by a factor of ≈ 2.5 at 3T in primates (1) and humans (2). We evaluated the use of ferumoxytol for CBV-RS-fMRI and steady state relative CBV (rCBV) mapping in healthy volunteers with a view to employing this methodology for monitoring the brains of patients in stroke/cerebral trauma recovery and rehabilitation.
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Methods: All procedures were approved by our local IRB board: 6 volunteers consented and enrolled in the study. A 3T GE Discovery MR 750HD scanner was used and the following sequences (before/after a bolus injection of 510mg ferumoxytol): 1) GRE-EPI 5min. resting state scans; TR 2400ms, TE 30 ms, 64 2 , 2.9 mm slice pre-injection; TE 20 ms 64 2 & 96 2 post-ferumoxytol. 2) Dual-echo FSE TE 13/102ms, 3) GRE 8-echo TE 3.67 -41ms, 4) Fast 4-slice GRE-EPI TR 250ms, TE 30 or 20ms. RS-fMRI data were processed using MELODIC (FSL, FMRIB, Oxford, UK) to generate Z score maps for independent components (IC). Pre/post R2, R2* and rCBV maps were calculated using MRVision (MRVision Co.,Redwood City, CA). Parametric rCBV maps were calculated as follows: [(R2* post-R2* pre )/blood iron concentration]. Z score, rCBV maps were transformed to MNI152 space. rCBV values were averaged over the visual (Vis) and default mode (DMN) networks and mean rCBV, Z-statistics were compared between BOLD and CBV RS-fMRI ICs. Fast RS-FMRI data were Fourier transformed to evaluate the effect of ferumoxytol on cardiac and respiratory fluctuations in the brain BOLD/CBV signals. Results: There were no adverse events following ferumoxytol infusion. All standard resting state networks (RSNs) were identified from BOLD and CBV ICs in all subjects at all resolutions. Figure 1 compares default mode and visual RSNs in one subject. On average the Z-scores and volumes of the Vis and DMN networks were comparable, however the absolute scale of signal fluctuations was greater with CBV contrast (median coefficient of variation increase 130%). There was a negative correlation between Z-scores in the DMN and rCBV for both BOLD and CBV contrast (R 2 = 0.63, 0.76) but not for the visual network. Overall there was relatively little variation in rCBV across subjects (coefficient of variation 15%). Intensity spectra from a fast acquisition are shown for the cortex and sagittal sinus, 
Discussion & Conclusions:
Ferumoxytol enhanced CBV-RS-fMRI is robust and shows the expected major networks similar to the BOLD effect at 3T. Increased cardiac, respiratory signals post ferumoxytol in some individuals suggests that correcting for these effects will be more important with CBV-RF-fMRI. The robustness of the CBV contrast may be advantageous in studies of patients where head motion is more problematic and taskbased paradigms are often challenging. In some individuals, additional areas of activation were observed within standard networks with CBV-RS-fMRI compared to BOLD. Further group analysis is underway. 
